International Journal of Clinical Case Reports, 2025, Vol.15, No.6, 259-270 http://medscipublisher.com/index.php/ijccr 270 Torrecilla F., Álvarez-Corral G., Pérez E., Morell-García D., Pérez J., Rodríguez B., Martín L., and Ruiz F., 2025, Budget impact analysis of the use of specific biomarkers GFAP and UCH-L1 in the management of mild traumatic brain injury in Spain, Journal of Clinical Medicine, 14(12): 4095. https://doi.org/10.3390/jcm14124095 Wang W., Shi J., Chen M., Zhuge X., Dai C., and Xie L., 2023, Calpain inhibitor MDL28170 alleviates cerebral ischemia- reperfusion injury by suppressing inflammation and autophagy in a rat model of cardiac arrest, Experimental and Therapeutic Medicine, 25(5): 196. https://doi.org/10.3892/etm.2023.11895 Wang W., Xie L., Zou X., Li N., Yang Y., Wu Z., Tian X., Zhao G., and Chen M., 2021, Inhibition of extracellular signal-regulated kinase/calpain-2 pathway reduces neuroinflammation and necroptosis after cerebral ischemia-reperfusion injury in a rat model of cardiac arrest, International Immunopharmacology, 93: 107377. https://doi.org/10.1016/j.intimp.2021.107377 Yao Z., Zhao Y., Lu L., Xu S., Li Y., and Yu Z., 2025, Proteomics identify pathogenesis and novel biomarkers for monitoring and early prognostication of brain injury after cardiac arrest: a randomized animal study, Resuscitation Plus, 26: 100993. https://doi.org/10.1016/j.resplu.2025.100993
RkJQdWJsaXNoZXIy MjQ4ODYzNA==